Small pharmacies grow in England as large branches decline
New data shows a split in how England's pharmacy sector is changing. Small pharmacies are growing in number while large branches are pulling back — and the National Pharmacy Association says closures point to "severe stress" across the sector.
What happened
Figures reported by Chemist+Druggist show small pharmacies have been increasing in England at the same time that larger pharmacy branches are declining. The NPA responded to the data by describing the situation as a sign of "severe stress" in the sector, linking the pattern of closures to wider financial and operational pressures facing community pharmacy.
The picture isn't a straightforward one of growth versus decline across the whole sector — it depends heavily on the type and size of the provider.
Why it matters
For anyone working through a pre-registration year right now, or who recently started as a newly registered pharmacist, the shape of the employer market is shifting. The balance between large and small pharmacy providers affects where jobs are, what those roles look like day to day, and how workload and supervision are structured.
Large pharmacy chains have traditionally offered high volumes of dispensing, structured workflows, and often more formalised training environments. Smaller independent pharmacies tend to operate with leaner teams and broader scopes of daily responsibility for every member of staff. Neither is inherently better for professional development — but they offer genuinely different experiences, and the data now suggests the sector is tilting toward more of the latter.
The NPA's language is worth sitting with. "Severe stress" isn't a throwaway description. Pharmacy representative bodies tend to speak carefully. When the NPA frames closures in those terms, it reflects a sector where viability is under real pressure — not just at the margins, but in ways that are affecting which businesses can keep their doors open.
For large branches specifically, the decline raises practical questions. A branch that closes or reduces its footprint affects the patients relying on it, the staff working there, and the surrounding healthcare infrastructure. Patients who lose a nearby pharmacy often turn to GP practices or urgent care settings instead, increasing pressure elsewhere in the NHS.
For smaller pharmacies, growth in numbers doesn't automatically mean growth in stability. Opening a small pharmacy and keeping it financially sustainable are different things. The same sector stress the NPA describes can affect smaller operators too, just in different ways. Without adequate funding and support, growth in the number of small pharmacies may not translate into a stronger, more accessible sector overall.
GPhC exam relevance
The GPhC assessment doesn't test commercial pharmacy data directly, but the professional and legal context that sits underneath these trends does appear in assessments.
Professional standards require registered pharmacists to act in patients' best interests regardless of the commercial pressures their employer faces. A pharmacy under financial strain can't pass that pressure onto clinical decision-making — the duty of care doesn't flex. Candidates should be confident applying that principle in scenario-based questions, particularly where the working environment described in a question is under-resourced or stretched.
Supervision is another area to think through. Smaller pharmacies may have fewer staff, which affects how dispensing supervision, responsible pharmacist duties, and oversight of accuracy checking technicians work in practice. The law on this is clear regardless of the size of the operation — the responsible pharmacist framework applies the same way in a two-person independent as it does in a large chain branch. Knowing that framework thoroughly, including what it requires and when the responsible pharmacist notice must be displayed, is the kind of foundational knowledge the assessment draws on.
Pharmacy ownership rules are also worth revisiting. There are restrictions in UK law on who can own a pharmacy business, and these apply differently depending on the structure of the business. With independent pharmacy ownership shifting, understanding the regulatory requirements around superintendents, legal ownership, and what bodies like the GPhC require from a pharmacy premises registration perspective gives useful professional grounding.
What's next
Watch how the NPA and other pharmacy bodies respond to this data publicly. If the sector framing shifts from individual closures to systemic pressure, that tends to precede formal calls for government intervention — contract renegotiation, emergency funding, or structural reform of how community pharmacy is commissioned and paid.
For anyone job-hunting or planning their post-registration career, it's worth actively researching both large and small pharmacy employers in areas you're considering. The sector data gives a macro picture, but local labour market conditions vary significantly. A region where large branches are contracting may still have independent pharmacies actively hiring — and vice versa.
If you're mid-training placement right now, pay attention to how the pharmacy you're working in handles the pressures the NPA is describing. How does your supervisor manage patient demand against available staff? How are clinical decisions made when the pharmacy is understaffed? These aren't abstract policy questions — they're the professional practice realities the registration assessment is designed to reflect.
Source: Chemist+Druggist — https://www.chemistanddruggist.co.uk/news/business/small-pharmacies-grow-in-england-as-large-branches-dip-data-shows-Z32UJXMGP5CI5C3SB6LH57RHJY/